Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
131.3 USD | +0.07% | +3.41% | +20.40% |
04:14pm | Merck Reports Positive Data for Investigational 21-Valent Pneumococcal Vaccine | MT |
08:52am | Blackstone beats Concord with $1.6 bln bid for Hipgnosis Songs | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.40% | 332B | |
+26.61% | 661B | |
+27.32% | 566B | |
-6.35% | 352B | |
+3.43% | 283B | |
+14.36% | 231B | |
+5.22% | 200B | |
-9.04% | 195B | |
-4.81% | 145B | |
-10.87% | 144B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Morgan Stanley Cuts Price Target on Merck to $116 From $118, Keeps Equalweight Rating